On February 8, 2023 BridgeBio Pharma, Inc. (Nasdaq: BBIO) ("BridgeBio" or the "Company"), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, reported that members of the management team will participate in the following upcoming investor conferences (Press release, BridgeBio, FEB 8, 2023, View Source [SID1234626954]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

SVB Securities Global Biopharma Conference, Virtual: Tuesday, February 14th at 2:20 pm ET
Goldman Sachs Bus Tour, San Francisco, CA: Wednesday, March 1st at 8:00 am PT
Cowen 43rd Annual Healthcare Conference, Boston, MA: Wednesday, March 8th at 10:30 am ET
To access the live webcast of BridgeBio’s fireside chats at the SVB Securities Global Biopharma Conference and the Cowen 43rd Annual Healthcare Conference, please visit the "Events" page within the Investors section of the BridgeBio website at View Source A replay of the webcasts will be available on the BridgeBio website for 90 days following the event.